MEGAN MCKENZIE: Open Payments
NPI 1245739564 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $209 |
| Novo Nordisk Inc | 3 | $64 |
| Exact Sciences Corporation | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| CeQur Corporation | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
Products named: VRAYLAR, Cologuard Collection Kit, QULIPTA, Ozempic, CAPLYTA, CeQur Simplicity, UBRELVY, Auvelity.
Industry payments across TN — which companies pay providers there.
